Contract W81K0022P0265
Immucor Inc · Department Of Defense · September 22, 2022
Immucor Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on September 22, 2022 for $154,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Jbsa Ft Sam Houston, TX. It was awarded under full and open competition. The contract has been modified 8 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 31, 2025.
Contract details
- PIID
- W81K0022P0265
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Jbsa Ft Sam Houston, TX
- First action
- September 22, 2022
- Latest action
- December 31, 2025
Description
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-22-P-00265 FOR THE PERIOD OF 1 OCTOBER
Modification timeline
-
December 31, 2025Mod P00008IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K0$42.5K
-
June 13, 2025Mod P00007PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-22-P-0265 WITH IMMUCOR, INC IS HEREBY EXTENDED FOR$0
-
June 5, 2025Mod P00006THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY23 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE CONTRACT IN FY23 (01 OC$-15.8K
-
December 13, 2024Mod P00005HEA 1.2 BEADCHIP KIT, SLIDE CT - FY25 FUNDING MODIFICATION.$42.5K
-
May 1, 2024Mod P00004HEA 1.2 BEADCHIP KIT, SLIDE CT - EXERCISE OF FY25 OPTION 2$0
-
November 17, 2023Mod P00003HEA 1.2 BEADCHIP KIT, SLIDE CT - FUNDING MODIFICATION$42.5K
-
May 4, 2023Mod P00002HEA 1.2 BEADCHIP KIT, SLIDE CT$0
-
November 2, 2022Mod P00001HEA 1.2 BEADCHIP KIT, SLIDE CT - FY23 FUNDING$42.5K
-
September 22, 2022Base awardREAGENTS & WARRANTY SERVICE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Quidelortho Sales Company, Llc | Department Of Defense | December 30, 2025 | $505.8K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0022P0265?
Contract W81K0022P0265 is a federal contract awarded to Immucor Inc by Department Of Defense on September 22, 2022 for $154,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 8 times since the base award.
Who won contract W81K0022P0265?
Immucor Inc won contract W81K0022P0265 from Department Of Defense.
How much is contract W81K0022P0265 worth?
Contract W81K0022P0265 has obligated $154,000 to date, with a total potential value of $206,000 if all options are exercised.